Kauvery Hospital Alwarpet achieves JCI accreditation, strengthening Chennai’s position as Asia’s healthcare capital: Our ...

DCOIWA observes Black Day against suspension of drug regulatory officers in MP: Our Bureau, Chennai Thursday, October 9, 2025 ...

Union govt to focus on quality-driven healthcare system for every citizen highlighted at FICCI HEAL 2025: Our Bureau, Bengaluru Thursday, October 9, 2025, 17:40 Hrs [IST] Union go ...

Bayer & Kumquat Biosciences initiate phase I study with KRAS G12D inhibitor in patients with KRAS-mutated tumours: Berlin, Germany Thursday, October 9, 2025, 17:00 Hrs [IST] Bayer ...

Union government working to achieve equitable, accessible and affordable healthcare by 2047: Our Bureau, Bengaluru Thursday, October 9, 2025, 17:15 Hrs [IST] Union government is n ...

Kernal Biologics receives $48 million fund from ARPA-H to develop lower cost in vivo CAR T-cell therapies for hematological cancers: Boston Thursday, October 9, 2025, 13:00 Hrs [I ...

MaaT Pharma reports positive second safety interim analysis from DSMB for phase 2b PHOEBUS trial of MaaT033 for patients receiving Allo-HSCT: Lyon, France Thursday, October 9, 202 ...

PharmaJet expands its injection portfolio with development of needle-free self-injection pens for home use: Golden, Colombia Thursday, October 9, 2025, 15:00 Hrs [IST] PharmaJet, ...

Lupin unveils strategic partnership programme to expand reach of its long-acting injectable platform: Our Bureau, Mumbai Thursday, October 9, 2025, 16:15 Hrs [IST] Global pharma m ...

Scottsdale, Arizona Thursday, October 9, 2025, 10:00 Hrs [IST] ...

US FDA grants orphan drug designation to Precision NeuroMed’s investigational therapy for glioblastoma: Redwood City, California Thursday, October 9, 2025, 16:00 Hrs [IST] Preci ...

Complement Therapeutics receives US FDA clearance to begin Opti-GAIN phase I/II trial of CTx001 in patients with GA secondary to AMD: Munich, Germany Thursday, October 9, 2025, 11 ...